GBP1 and ovarian carcinoma: Furthermore, high GBP1 expression may also act as a mediator of paclitaxel resistance in human ovarian cancer cell lines (Wadi et al., 2016) and radioresistance in a variety of cancer cell lines (Fukumoto et al., 2014).